Yamada T, Sasaki H, Dohura K, Goto I, Sakaki Y
Research Laboratory for Genetic Information, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Biochem Biophys Res Commun. 1989 Feb 15;158(3):906-12. doi: 10.1016/0006-291x(89)92808-8.
The human amyloid beta protein (BP) is a major constituent of the amyloid deposited in the brain of patients with Alzheimer's disease and is derived from a larger precursor protein (BPP). In human three alternatively-spliced forms of BPP mRNA were found and two of them were shown to encode a protease inhibitory activity. We have isolated the corresponding species of cDNA in mice and found that the inhibitor domain is highly conserved through mammalian evolution. The homology between human and mouse was 94.6%. Northern blot using specific probes showed that the mRNA for BPP with inhibitor domain was present in every tissue, particularly at a higher level in the kidney. On the other hand, that without inhibitor domain was found most abundantly in the brain but much less in the kidney and the intestine. These data suggest that the individual BPP mRNA species were produced in a tissue-specific manner in mouse as in the case of human.
人类淀粉样β蛋白(BP)是沉积在阿尔茨海默病患者大脑中的淀粉样蛋白的主要成分,它来源于一种更大的前体蛋白(BPP)。在人类中发现了三种选择性剪接形式的BPP mRNA,其中两种被证明编码蛋白酶抑制活性。我们已经从小鼠中分离出了相应的cDNA物种,发现抑制剂结构域在哺乳动物进化过程中高度保守。人与小鼠之间的同源性为94.6%。使用特异性探针进行的Northern印迹显示,具有抑制剂结构域的BPP的mRNA存在于每个组织中,特别是在肾脏中含量较高。另一方面,没有抑制剂结构域的BPP在大脑中含量最高,但在肾脏和肠道中含量要少得多。这些数据表明,与人类情况一样,小鼠中各个BPP mRNA物种是以组织特异性方式产生的。